Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
645 A phase 1B/2, open-label study of Q702 in combination with intravenous pembrolizumab in patients with selected advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
